← Back to news
S

Seeking Alpha: News

Cboe Global Markets raises dividend by 19% to $0.86

B

Firm Capital Mortgage Investment declares C$0.078 dividend

B

RCM Technologies Non-GAAP EPS of $0.82 beats by $0.12, revenue of $93.8M beats by $11M

B

Agora Non-GAAP EPS of $0.02, revenue of $40.4M; gives Q3 outlook

B

OpenAI’s revenue run rate tops $40B ahead of planned Wall Street debut: report

S

Innventure signals shift to milestone reporting as Accelsius targets adoption in a projected $9B 2030 two-phase market

S

Celcuity plans late Q3 2026 REVTORPYK shipments and targets sNDA submission in Q3 2026

S

HawkEye 360 outlines $215M-$220M 2026 revenue outlook while targeting 10-minute revisit and latency in 2-3 years

S

Nektar outlines REZPEG Phase III timeline with mid-2028 data and 2029 BLA plan

S

Elutia anticipates NXT-41x clearance in 1H 2027 while targeting >80% gross margins at scale

S

Health In Tech reaffirms $45M-$50M 2026 revenue guidance while preparing HitRix launch in the second half

S

AmpliTech outlines 2026 priorities while declining to reaffirm $50M full-year revenue guidance amid deployment timing shifts

B

Blaize forecasts $40M-$43M 2026 revenue amid Starshine reserve and memory inflation

B

Sensus outlines shift to $250,000 average selling price as it targets a stronger second half

B

Rekor targets adjusted EBITDA profitability in H2 2026 as GoSecure expands into audio

S

Tenon outlines sacropelvic launches over next six to nine months following FDA 510(k) clearance

S

Daré Bioscience targets Ovaprene top-line data in 2027 as it plans DARE to PLAY dispensing this quarter

S

Caliber projects $18M-$22M 2026 revenue while expanding tokenization to an initial ~$100M slate of managed assets

S

AudioEye expects over $15M run rate adjusted EBITDA by end of 2026 as it raises full-year adjusted EBITDA guidance to at least $12.7M

S

Jefferson Capital outlines $1.1B expected ERC collections in next 12 months while entering Mexico market

B

FocalTherics reiterates $50M-$54M 2026 HIFU revenue outlook as it closes $40M equity offering

B

Cibus updates Latin America rice launch to 2028 while outlining $20M-$40M biofragrance revenue opportunity

B

International Money Express jumps after New York approves Western Union deal (update)

B

CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission

B

Smith Micro expects Q3 2026 revenue of $5.0M-$5.4M as SafePath launches move into Q3

B

TSS maintains full-year adjusted EBITDA outlook toward upper end of $20M-$22M range as $17M Vera Rubin buildout nears September completion

B

Genasys signals fiscal 2026 record year outlook as it expects to complete initial $9M CROWS delivery within the year

B

SoundThinking outlines $99M-$100M 2026 revenue plan while targeting 8%-9% adjusted EBITDA margin

B

Cineverse outlines $13M annual cost cuts while targeting $115M-$120M FY2027 revenue

B

Pedevco reiterates $60M-$70M 2026 adjusted EBITDA guidance while planning 20+ gross wells

S

Xos outlines 2026 revenue of $35M-$43M as Power Hub launch expands focus to power infrastructure

S

Newsmax reiterates $212M-$216M 2026 revenue guidance while targeting about $16M in international licensing fees

S

NextBoat outlines $165M-$170M 2026 revenue guidance while expanding MarineMax partnership and warranty rollout

S

Bit Digital expects WhiteFiber to reach full contracted run-rate billing under $865M Nscale agreement later this month

S

Laird Superfood reaffirms 2026 net sales of $138M-$148M and adjusted EBITDA of $8M-$12M as Terrasoul integration begins

S

Oil prices snap winning streak on demand concerns, U.S. inventory build

S

Digimarc outlines go-to-market rebuild as Secure Gift Card pipeline grows over 30x to more than 31 retailers

S

Intellicheck expects GAAP profitability in 2026 as a 29% revenue customer evaluates a multi-vendor IDV approach

S

TMC targets 3M wet tonnes/year system as NOAA timing shifts to October 2026 certification

S

Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance

B

Capricor outlines BLA amendment plan as FDA signals willingness to review, with PDUFA date set for August 22

B

CV Sciences outlines hemp-rule delay to December 11, 2026 while expanding PlusHLTH.com and planning multiple 2026 launches

B

Oxbridge outlines AI GridWorks targeting 10-100 MW data center projects while expanding tokenized reinsurance offerings

B

Aethlon outlines plan to complete oncology trial follow-up by end of 2026 while targeting 12 months of runway

B

PetMeds outlines $37M sale-leaseback while expecting the deal to close within about 120 days

B

Swarmer outlines ~80% gross margin target while scaling SkyKnight contract to ~$14.2M

B

TechPrecision outlines $52M backlog delivery over 1 to 3 fiscal years while maintaining FY2027 guidance

S

Trump slaps tariffs on drone imports, says U.S. too reliant ​on foreign sources

S

FitLife outlines plan to launch at least 4 new Irwin products per quarter beginning in 2027 amid supply chain and Amazon initiatives

S

KULR outlines Texas facility going operational in Q3 as it exits Bitcoin mining and repays $20M credit facility

S